Jane Street’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.94M Buy
90,331
+30,136
+50% +$3.63M ﹤0.01% 2932
2026
Q2
$8.02M Sell
60,195
-33,946
-36% -$3.84M ﹤0.01% 3097
2026
Q1
$10.5M Sell
94,141
-329,116
-78% -$38.9M ﹤0.01% 2478
2025
Q4
$57.1M Buy
423,257
+355,455
+524% +$38.8M 0.01% 857
2025
Q3
$5.76M Buy
+67,802
New +$4.16M ﹤0.01% 3213

Other funds holding ABVX

Jane Street's ABVX Position: Q3 2026 in Review

Jane Street increased its Abivax (ABVX) stake by 50% in Q3 2026, buying an estimated $3.63M and bringing the position to 90,331 shares worth $8.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Jane Street first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $57.1M in Q4 2025. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Jane Street held 90,331 shares of Abivax worth $8.94M as of Q3 2026.
  • Jane Street bought 30,136 Abivax shares in Q3 2026, an estimated $3.63M.
  • Abivax made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #2932 holding.
  • Jane Street first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
  • Jane Street's Abivax position peaked at $57.1M in Q4 2025.
  • 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.